C
Tierney, Lawrence M., McPhee, Stephen J., Papadakis, Maxine A.
Current Medical Diagnosis & Treatment, 45th Edition
document.getElementById('working').innerHTML = ''; function hide_scrollbar() { var e = document.body; e.style.scrollbarBaseColor = '#fff'; e.style.scrollbarArrowColor = '#fff'; e.style.scrollbarDarkShadowColor = '#fff'; e.style.scrollbarShadowColor = '#fff'; } function show_scrollbar() { var e = document.body; e.style.scrollbarBaseColor = '#ccc'; e.style.scrollbarArrowColor = '#000'; e.style.scrollbarDarkShadowColor = '#000'; e.style.scrollbarShadowColor = '#666'; } function toggle_CA(e) { var src; src = window.parent.getSrc(e); if (src.nextSibling.style.display == 'block') { src.nextSibling.style.display='none'; src.innerHTML='View Answer'; } else { src.nextSibling.style.display='block'; src.innerHTML='Hide Answer'; } } function resolve_link(e,setid,locator,dbid,toan) { e.href = "ovidweb.cgi?S=IDNJHKKKJGEPJK00D;FTS+Link+Set+Ref=" + setid + "|" + locator + "|" + dbid + "|" + toan; return true; }
G
G6PD, deficiency of See Glucose-6-phosphate dehydrogenase deficiency
GM1 ganglioside, for spinal trauma 1021
G20210A prothrombin mutation, in noncirrhotic portal hypertension 680
GABA See Gamma-aminobutyric acid
Gabapentin 984
for neuropathic pain/painful diabetic neuropathy 79 80 1223
for phobic disorder 1046
for seizures 983 984
GABHS See Group A beta-hemolytic streptococcal infection
GAD 65 antibodies, in type 1 diabetes 1195 1196
P.1798
Gait/gait disorders See also Falls
in elderly 60–62 61
screening for 51 52 53
in parkinsonism 1008
in spinal stenosis 820
in tabes dorsalis 1451
Galactomannan, in invasive aspergillosis 1544
Galactorrhea 1114
α-D-Galactosidase enzyme (Beano), for gastrointestinal gas 545
Galantamine, for dementia 1093
Galerina mushroom poisoning 1629
Gallaverdin phenomenon 333
Gallbladder
carcinoma of 692–693
cholesterolosis of 685 687
disorders of
in clonorchiasis/opisthorchiasis 1506
during pregnancy 685 782–783
gangrene of 687
hydrops of 687
porcelain 685 687
removal of See Cholecystectomy
stones in See Cholelithiasis
strawberry 687
Gallium nitrate
for cancer-related hypercalcemia 1691
for chemotherapy-induced toxicity/bone pain 1678
Gallium scanning
in infectious myocarditis 399
in tumor size evaluation 1686
Gallstone ileus 685
Gallstones See Cholelithiasis
Gambian trypanosomiasis 1463–1465
Gamete intrafallopian transfer (GIFT) 750
Gamma-aminobutyric acid (GABA), in Huntington's disease 1011
Gamma benzene hexachloride See Lindane
Gamma (γ) chain disease 798
Gamma globulin, intravenous See Intravenous immune globulin
Gamma-glutamyl transpeptidase (GGTP) levels
alcohol use/abuse and 1085
laboratory reference range for 1738
in liver disease/jaundice 650
Gamma-hydroxybutyrate, overdose/toxicity of 1625
Gamma-hydroxybutyrolactone, overdose/toxicity of 1625
Gamma interferon See Interferon-γ
Gamma knife radiation/gamma radiosurgery 1659
for acromegaly 1112
for intracranial arteriovenous malformations 998
for pituitary adenoma 1112 1115 1169
for thyroid cancer brain metastases 1127
for trigeminal neuralgia 979
Gammopathy 796–798
monoclonal 796
neuropathy associated with 1025
of unknown significance (MGUS) 516 797
polyclonal 796
Ganciclovir 1352 1588
cost of 1561 1562
for cytomegalovirus infection treatment/prophylaxis 168 176 1290 1335 1347 1352 1361 1588
prophylactic 1290 1588
therapy adjustments in renal or hepatic failure and 1558
Ganglioneuromas, in multiple endocrine neoplasia 1150 1192
Gangrene
bacterial synergistic 1435
of feet, in diabetes mellitus 1225
of gallbladder 687
gas 1408–1409
Ganja 1088
Gardnerella infection, vaginal 732
Garlic 1712 1714–1715
Gas
gastrointestinal 544–545
in urine (pneumaturia) 932
Gas gangrene 1408–1409 1553
Gasoline, sniffing 1090
Gastrectomy
for gastric cancer 598
hypoglycemia after 1234 1234 1238
vitamin B12 deficiency and 487
Gastric acid/gastric contents
aspiration of See also Aspiration
acute (Mendelson's syndrome) 295
chronic 294–295
in comatose patient 1607
hospital-acquired pneumonia and 253
examination of in tuberculosis diagnosis 257–258
hypersecretion of, in Zollinger-Ellison syndrome/gastrinoma 595 1178
inhibition of secretion of See Acid-antisecretory agents; Antacids; H2 receptor blocking drugs; Proton pump inhibitors
radiation affecting secretion of 1600
reflux of See Gastric acid refluxate; Gastroesophageal reflux disease
Gastric acid refluxate See also Gastroesophageal reflux disease
abnormal clearance of 565–566
irritant effects of 565
Gastric anisakiasis 585 1516
Gastric bypass, for obesity 14 1099 1269
Gastric cancer 596–600 597 1664
adenocarcinoma 596–598 597
Helicobacter pylori infection and 584 597 1644
carcinoid tumors 599
dyspepsia in 536 597
Helicobacter pylori gastritis and 584 597 1644
lymphoma 598–599
Helicobacter pylori infection and 584 598–599 1644
mesenchymal tumors 599–600
peptic ulcer disease and 591 598
pernicious anemia gastritis and 585
upper gastrointestinal bleeding in 552 597
Gastric emptying, delayed, in gastroesophageal reflux disease 566
Gastric emptying study, in chronic intestinal pseudo-obstruction/gastroparesis 609
Gastric intubation, in corrosive acid/alkali ingestion 1617
Gastric lavage, for poisoning/drug overdose 1611–1612
Gastric mucosal biopsy, in gastric adenocarcinoma 597 598
Gastric neoplasms See Gastric cancer; Stomach disorders, tumors
Gastric outlet obstruction
in peptic ulcer disease 594
vomiting and 538 539
Gastric pH
nosocomial pneumonia and 253
in Zollinger Ellison/gastrinoma 595
Gastric polyps 596
Gastric ulcers 74 586 587
malignant 591 598
refractory 591
Gastric varices, gastrointestinal bleeding from 551–552
in noncirrhotic portal hypertension 680
Gastrin
D cells secreting 1178
hypersecretion of in pernicious anemia gastritis 585
in Zollinger-Ellison syndrome/gastrinoma 595 596 1178
laboratory reference range (normal values) for 1738
proton pump inhibitors affecting 588
Gastrinoma (Zollinger-Ellison syndrome) 595–596 1178
carcinoid tumors and 599
in multiple endocrine neoplasia 595 596 1178 1191
peptic ulcer disease and 591 595 1178
perforation and 593
Gastritis 582–600
alcoholic 583
atrophic
Helicobacter pylori infection and 584
in pernicious anemia 487 585
eosinophilic 585
erosive/hemorrhagic 582–584
gastrointestinal bleeding and 552 582
granulomatous 585
Helicobacter pylori 584–585
gastric cancer and 584 594 1644
lymphocytic 585
nonerosive/nonspecific 584–585
NSAID 583
in pernicious anemia 487 585
phlegmonous/necrotizing 585
stress 583
gastrointestinal bleeding and 552 583
in respiratory failure 309 583
Gastroduodenal surgery, antibiotic prophylaxis for 47
Gastroenteritis 545 1556
adenovirus causing 1299 1387
amebic 545 546 549 550 1299 1467–1472 1471 1556
Bacillus cereus causing 545 1300 1302
campylobacter 545 1299 1300 1301 1302 1428–1429 1556
Guillain-Barr syndrome and 1027
clostridial 545 546
coccidial and microsporidial 1475–1478
eosinophilic, dog hookworm causing 1526
Escherichia coli causing 545 546 1299 1300 1302 1427
irritable bowel syndrome and 615–617
in measles 1363
salmonella causing 545 1300 1301 1303 1426 1556
shigella causing (shigellosis) 545 1299 1300 1301 1303 1426–1427 1556
staphylococcal 545
viral 545 1299 1389
Yersinia enterocolitica causing 545 546 1299 1303
Gastroesophageal junction
stricture at See Esophagus, strictures of
tear at See Mallory-Weiss syndrome
P.1799
Gastroesophageal reflux disease 565–570
Barrett's esophagus and 566–567
chest pain in 566 581
chronic gastric aspiration and 294
cough and 21 22 219 566
dyspepsia in 536
heartburn in 564
hoarseness and 210
peptic stricture and 567
Gastrointestinal bleeding 551–558
acute
lower 554–557
upper 551–552
anorectal disease causing 554 555
aspirin and 556
in cirrhosis 574 670
diverticular 554 555 556 633
in erosive/hemorrhagic gastritis 552 582
from gastrointestinal/esophageal varices 551–552 573–576
in noncirrhotic portal hypertension 680
hemorrhoids causing 555
iron deficiency and 482 557
Mallory-Weiss syndrome and 552 572
NSAIDS and 74 556 830
obscure 557–558
occult 557–558
stool test for See Fecal occult blood testing
in peptic ulcer disease 551 592–593
in portal hypertension 551–552
in portal hypertensive gastropathy 552 583
risk assessment in patients with 553
in stress gastritis 552 583
in typhoid fever 1425
from vascular ectasias 552 554–555
Gastrointestinal fluid losses, replacement guidelines for 894 895
Gastrointestinal gas 544–545
Gastrointestinal irritant-type mushroom poisoning 1629 1630 1630
Gastrointestinal stromal tumor (GIST)
chemotherapy for 1669
of small intestine
benign 610
malignant 612
of stomach 599
Gastrointestinal system 536–548
decontamination of, in poisoning/drug overdose 1607 1611–1613
disorders of 536–558
in anisakiasis 585 1516
in anthrax 1412 1413
in ascariasis 1518
cancer, paraneoplastic syndromes associated with 1696–1697
chemotherapy-induced 1683
cytomegalovirus infection and 1360–1361
in fasciolopsiasis 1504–1505
functional
dyspepsia (nonulcer dyspepsia) 536 537–538
irritable bowel syndrome 615–618
noncardiac chest pain and 344 581–582
in HIV infection/AIDS 1326–1327
in hyperoxaluric calcium nephrolithiasis 946
motility See Motility disorders
mushroom poisoning causing 1629 1630 1630
radiation causing 1600 1683
in schistosomiasis 1501 1502
in scleroderma 838 839
in strongyloidiasis 1530
in syphilis 1450
tetracycline causing 1571
in trichinosis 1532 1533
in trichuriasis/whipworm 1533
Gastroparesis 609–610
in diabetics 609 1224
dyspepsia in 536
vomiting and 538
Gastropathy 582–600
erosive/hemorrhagic 582–584
gastrointestinal bleeding and 552 582
in HIV infection/AIDS 1327
hypertrophic (M n trier's disease) 585
portal hypertensive 583
gastrointestinal bleeding in 552 583
Gastroscopy, in anisakiasis 1516
Gastrostomies 1280–1281
Gatifloxacin 1579 1580 1580 1581
cost of 1561 1562
ophthalmic 175
Gaucher cells 1706
Gaucher's disease 1705–1706
Gaze-evoked nystagmus 152
GBE See Ginkgo biloba
GBL (gamma-hydroxybutyrolactone), overdose/toxicity of 1625
GBM antibodies See Anti-glomerular basement membrane antibodies
GBP See Gastric bypass
G-CSF (granulocyte colony-stimulating factor) See Filgrastim
Gefitinib 1669–1670 1676 1699
Gellhorn pessary, for uterine prolapse 741
Gemcitabine 1666 1675
Gemfibrozil 341 1250 1251
Gemifloxacin 1580 1580 1581
cost of 1562
therapy adjustments in renal or hepatic failure and 1558 1580
Gemtuzumab ozogamicin 1668 1676
Gender, cancer incidence/risk/mortality and 1639–1640 1640
Gender identity disorder (gender dysphoria) 1053
Gene expression analysis, in cancer 1642
treatment targeting and 1642
Gene probes See Nucleic acid probes
Gene therapy, for cancer 1700–1701
General well-being, evaluation of cancer treatment response and 1688–1689
Generalized anxiety disorder 1043
Generalized seizures 981–982 981 982–983 984
Genetic counseling See also Genetic testing; Prenatal testing
cancer screening and 1643
prenatal testing and 765
Genetic disorders 1703–1708
Genetic instability, in hereditary nonpolyposis colorectal cancer (HNPCC) 636–637 1643
Genetic testing See also specific disorder and Prenatal testing
for cancer susceptibility genes 1643
APC gene mutation 635 637 1643
breast cancer and 706 1643
colorectal cancer and 635 636 636–637 637 642 1643
hereditary nonpolyposis colorectal cancer and 636–637 1643
MYH gene mutation 635
for familial Mediterranean fever 563
for hemochromatosis 677
for Huntington's disease 1011
Genistein, in cancer prevention 1653
Genital herpes 108–109 1350
during pregnancy/neonatal infection 778–779 1351 1353
Genital prolapse 741
Genital reconstruction surgery, for transsexuals 1053 1054
Genital ulcers
adenovirus causing 1387
in Beh et's syndrome 851
in chancroid 1433
in granuloma inguinale 1433
herpetic See Genital herpes
in lymphogranuloma venereum 1440
Genital warts See Venereal (genital) warts
Genitourinary system See also specific organ or structure
disorders of 931–973
benign prostatic hyperplasia 954–961 956 958 959
hematuria in 931–932 935–936
history in 931–932
infections 936–943 939
irritative voiding symptoms in 932
male erectile and sexual dysfunction 950–954
malignant 961–973
obstructive voiding symptoms in 932
pain in 931
physical examination in 933–934
in schistosomiasis 1501 1502
systemic manifestations of 932
ulcers See Genital ulcers
urinalysis in 934–935
urinary incontinence 62–64 62 932 947–950
urinary stone disease 943–947 944
evaluation of 931–935
Genomic hybridization, comparative, cancer development studied with 1641
Genotypic resistance testing, in antiretroviral therapy 1344–1345 1344 1345
Genotyping, cancer treatment and 1642
Gentamicin 1572 1572 1574
for anaerobic intra-abdominal infections 1435
cost of 1561
for endocarditis prophylaxis 1417 1418 1418
for hair cell destruction in vertigo 193
monitoring concentrations of 1734
for ophthalmic disorders 175
resistance to 1574
therapy adjustments in renal failure and 1572 1573
for urinary tract infections 939
Geodon See Ziprasidone
GERD See Gastroesophageal reflux disease
Geriatric Depression Scale 53
Geriatric medicine 49–66
approach to older patient and 49–55 50 51
assessment of elderly and 50–54 53 54
common problems in frail elderly and 55–66
general principles of 49
preventive care and 54–55
psychiatric disorders and 1094–1095
P.1800
Geriatric screen 50 51
Germ cell tumors, testicular 971–973 1182
Germline testing, in hereditary nonpolyposis colorectal cancer 636–637 1643
Gerstmann-Str ussler-Scheinker disease 1375
Gerstmann's syndrome 1001
Gestational diabetes 776–777 777
screening for 765 777
Gestational hyperthyroidism See Hyperthyroidism (thyrotoxicosis), during pregnancy
Gestational trophoblastic disease 773–774 1665
hyperthyroidism in 774
paraneoplastic syndromes associated with 1696–1697
Gestodene, in oral contraceptives, thromboembolism and 753
GFR See Glomerular filtration rate
GGTP levels See Gamma-glutamyl transpeptidase (GGTP) levels
GH See Growth hormone
GHB (gamma hydroxybutyrate), overdose/toxicity of 1625
Ghon complex, in tuberculosis 258
Ghrelin, in obesity 1098
Giant cell (temporal/cranial) arteritis 846–847
headache in 846 977
optic neuropathy and 169 846
retinal artery occlusion and 166
Giant cell myocarditis 399
Giant cell thyroiditis See Subacute (de Quervain's) thyroiditis
Giant cell tumor of bone (osteoclastoma) 862
Giant congenital melanocytic nevi 93
Giardia antigen assay, stool 546 550 1479
Giardia lamblia/intestinalis/duodenalis (giardiasis) 545 546 549 550 1299 1301 1478–1480
GIFT See Gamete intrafallopian transfer
Gigantism 1110–1112
Gilbert's syndrome 649 651
Gilles de la Tourette's syndrome 1013–1014
Gingivitis
in HIV infection/AIDS 1326
necrotizing ulcerative 204
Gingivostomatitis See also Gingivitis; Stomatitis
herpetic 108 204
Ginkgo biloba 1712 1715–1716
for dementia 57 1712 1715
for lower extremity occlusive disease 454 1715
Ginseng 1712 1717–1718
GIST See Gastrointestinal stromal tumor
Gitelman's syndrome 874
Glanders 1553
Glanzmann's thrombasthenia 523 525
Glaucoma
acute angle-closure 151 159–160
inflammation/redness caused by 151 153 159
pupillary dilation precipitating 153 159 177
chronic 160–162
in diabetes mellitus 1221
drug therapy for 161 173–174
in elderly 65
facial pain caused by 979
neovascular (rubeotic), retinal vein occlusion and 165
normal-tension 160 161
Gleason grading system, for prostate cancer 964
Gleevec See Imatinib mesylate
Gliadin, in celiac disease 601 602
Gliclazide 1207 1209
Glimepiride 1207 1209
Glioblastoma multiforme 1000
Gliomas 999
brain stem 1000 1001
spinal 1003
Gliosis, in multiple sclerosis 1014
Glipizide 1207 1209
intensive therapy with 1203–1205
Globin chain synthesis, in thalassemias 484
α-Globin gene 484 484
in alpha thalassemia syndromes 484 484
β-Globin gene 484 484
in beta thalassemia syndromes 484 484
in sickle cell syndromes 493
Glomerular filtration rate 898–899 898 899
aging affecting 930
alkalosis in alkali administration and 892
in diabetic nephropathy 923
hypotonic hyponatremia and 867
in prerenal azotemia 902
radionuclide studies in evaluation of 899
in renal failure 907 907
Glomerular proteinuria 897
Glomerular sclerosis/glomerulosclerosis
in diabetic nephropathy 923
focal segmental 920 922
in systemic lupus erythematosus 924
Glomerulonephritis 901 905–906 916 917
acute renal failure caused by 901 905–906
anti-glomerular basement membrane (anti-GBM) 905 916 918–919
cryoglobulin-associated 850 916 919
in Goodpasture's syndrome 293 916 918–919
HLA in 801
IgA nephropathy (Berger's disease) 915–917 916 917
immune-complex 905
membranoproliferative 916 920 924–925
hepatitis C infection and 655 924
in microscopic polyangiitis 849 916
nephritic presentation of 914–915 916 917
nephrotic presentation of 914 919–921 920
pauci-immune (ANCA-associated) 799 905 905–906 916 918
peri-infectious 915 916
postinfectious 915 916 917 1400
rapidly progressive 914–915 917
in systemic lupus erythematosus 835 916 924
in Wegener's granulomatosis 848 916
Glomerulonephropathies 914–921
coxsackievirus infection and 1390
membranoproliferative 916 920 924–925
hepatitis C infection and 655 924
sickle cell 929–930
Glomerulosclerosis See Glomerular sclerosis/glomerulosclerosis
Glomus tumors (tympanicum/jugulare) 187
Glossitis 203–204
Glossodynia 203–204
Glossopharyngeal neuralgia 979
earache in 187
headache in 974
Glottic (true vocal cord) cancer (TVC) 211 212 212
GLP-1 See Glucagon-like peptide 1
Glucagon
A cells secreting 1178
for beta-adrenergic blocker overdose/toxicity 1620
for insulin reaction 1220
in insulinoma diagnosis/treatment 1236 1237
lack of response to, hypoglycemia in type 1 diabetics caused by 1220
Glucagon-like peptide 1 (GLP-1), for diabetes mellitus 1212
Glucagonomas 1178 1191
β-Glucocerebrosidase, in Gaucher's disease 1705 1706
Glucocorticoid-remediable hyperaldosteronism 874
Glucocorticoids 1192–1193
clinical use of 1192–1193 1193
Cushing's syndrome caused by 1167
deficiency of See also Adrenocortical insufficiency
familial 1165
perioperative administration of 46
for prostate cancer 966
Glucokinase gene defect, in maturity-onset diabetes of young (MODY) 1197
Glucometers, for self-monitoring blood glucose 1200
Glucophage See Metformin
Glucosamine sulfate plus chondroitin 810 1721–1722 1721
Glucose See also Glucose tolerance/intolerance
ascitic fluid 560 561
blood levels of See also Hyperglycemia; Hypoglycemia
in diabetes mellitus 1217
continuous monitoring of 1200–1201
control of See Glycemic control in diabetes
pregnancy and 776 777
self-monitoring of 1200 1217
surgery and 45–46 45
in diabetic coma 1228 1228
in diabetic ketoacidosis 1228–1229 1228
in hyperglycemic hyperosmolar state 1228 1231 1232
in insulinoma 1235
laboratory reference range (normal values) for 1738
monitoring/management of during surgery 45–46 45
prebreakfast hyperglycemia and 1218–1219 1219
testing 1199 1199
in pregnancy 765 777
cerebrospinal fluid, in CNS infection 1294
in diabetic ketoacidosis management 1230
drugs affecting absorption of 1208 1211
for hyperkalemia 876 877
hyperosmolality caused by 872
for hypoglycemia 1220
in hypoglycemia 1233
intraoperative administration of 45
joint fluid 807 808
pleural fluid 301
in urine See Glycosuria
Glucose-dependent insulinotropic polypeptide 1 (GIP1), in diabetes mellitus 1212
Glucose-6-phosphate dehydrogenase 491
Glucose-6-phosphate dehydrogenase deficiency 492
chloroquine therapy and 1492
dapsone therapy and 1347
primaquine therapy and 1494
sulfasalazine therapy and 832
P.1801
Glucose-6-phosphate dehydrogenase screen, laboratory reference range for 1738
Glucose tolerance/intolerance See also Diabetes mellitus
in Cushing's syndrome 1168
in diabetes mellitus 1199 1199
functional hypoglycemia and 1238
laboratory reference range (normal values) for 1199 1738
lithium affecting 1076
in pancreatic and periampullary carcinoma 700
in pregnancy 776
in renal failure 911
testing 1199 1199
in pregnancy 765 777
Glucose toxicity, in type 2 diabetes 1196
Glucose transporters, thiazolidinediones affecting expression of 1210
a-Glucosidase inhibitors, for diabetes mellitus 1208 1211
Glucosuria See Glycosuria
Glucotrol See Glipizide
Glucovance See Glyburide, with metformin
GLUT 1/GLUT 4 See Glucose transporters
Glutamic acid decarboxylase antibodies, in type 1 diabetes 1195 1196
Glutamine, laboratory reference range for 1738
g-Glutamyl transpeptidase (GGTP) levels
alcohol use/abuse and 1085
laboratory reference range for 1738
in liver disease/jaundice 650
Glutathione reductase, in riboflavin deficiency 1273
Gluten enteropathy (celiac disease/sprue) See Celiac disease
Gluten-free diet, for celiac disease/dermatitis herpetiformis 113 601 603
Glyburide 1207–1209 1207
intensive therapy with 1203–1205
with metformin 1208 1211
Glycated (glycosylated) hemoglobin See Hemoglobin A1/A1a/A1b/A1c
Glycemic control in diabetes
acceptable levels of 1219–1220
complications rate and, clinical studies of 1202 1203–1205
glycated hemoglobin (hemoglobin A1) measurements in evaluation of 1199–1200 1202 1203 1204 1205 1218 1220
nephropathy development/progression and 923 1202 1204 1222
pregnancy and 776 777
retinopathy development/progression and 167 1202 1204
self-monitoring of blood glucose and 1200 1217
surgery and 45–46 45
Glycogen storage disease, hepatic adenomas in 683
Glycohemoglobins See Hemoglobin A1/A1a/A1b/A1c
Glycoprotein Ib receptor, in hemostasis 523
in Bernard-Soulier syndrome 523 525
Glycoprotein IIb/IIIa receptors
drugs blocking
for acute coronary syndromes 352 353
for myocardial infarction 353
with PTCA/stenting 350 351 353
in hemostasis 523
Glanzmann's thrombasthenia and 523 525
Glycosuria/glucosuria 934
in diabetes mellitus 1198 1199
ketoacidosis and 1228 1228
in diabetic coma 1228 1228
hypernatremia and 871
nondiabetic (renal) 1201
in pancreatic and periampullary carcinoma 700
in pregnancy 1201
Glycosylated (glycated) hemoglobin (hemoglobin A1) See Hemoglobin A1/A1a/A1b/A1c
Glycosylphosphatidylinositol (GPI) anchor deficiency, in paroxysmal nocturnal hemoglobinuria 491
Glynase See Glyburide
Glyset See Miglitol
GM1 ganglioside, for spinal trauma 1021
GM-CSF (granulocyte macrophage colony-stimulating factor) See Sargramostim
Gnathostoma spinigerum (gnathostomiasis) 1524
GnRH analogs See Gonadotropin-releasing hormone (GnRH) analogs
Goeckerman regimen, for psoriasis 98
Goiter 1119–1122 1120
endemic 1130–1131
hyperthyroidism and 1130 1131 1137
hypothyroidism/cretinism and 1130 1131
lithium causing 1076
multinodular (nodular) 1120 1122
toxic 1140–1141
substernal 1130
Gold therapy
adverse ocular effects of 179
breast feeding and 785
Goldie-Coldman hypothesis 1660
Golf elbow 824
GoLYTELY See Polyethylene glycol
Gonadal dysgenesis (Turner's syndrome) 1189–1190 1190
amenorrhea caused by 1183 1184 1189
thyroiditis and 1144
Gonadoblastoma, testicular 971
Gonadotropin-releasing hormone (GnRH)
deficiency of, in amenorrhea 1183 1184
for ovulation induction 750
Gonadotropin-releasing hormone (GnRH) analogs See also Luteinizing hormone-releasing hormone (LHRH) analogs
for cancer chemotherapy 1674
for endometriosis 740
hypogonadotropic hypogonadism and 1106
Gonadotropins
cancer-related production of 1696
deficiency of 1104–1105
in amenorrhea 1183
human chorionic (hCG) See Human chorionic gonadotropin
human menopausal (hMG), for ovulation induction 750
Gonococcal infections/gonorrhea 1431–1433 1552
anorectal involvement and 645 1431 1432
arthritis and 856–857 1432
cervicitis 1432
chlamydial coinfection and 1432 1441
conjunctivitis 156 1432
disseminated 1432
drug resistant 1432
epididymitis in 943 1431 1556
pelvic inflammatory disease 741 742 1432 1433 1557
pharyngitis 1432
during pregnancy 780
rape/sexual assault in transmission of 759 1297
urethritis 1431–1432 1432 1556
Goodpasture's syndrome 293 918–919
glomerulonephritis in 293 905 906 916 918–919
HLA in 801 918
Gordon syndrome (pseudohypoaldosteronism type II) 874
Goserelin 1674
GOT See Aspartate aminotransferase
Gottron's sign 840
Gout/gouty arthritis 810–814 811 813
renal manifestations of 811 930
rheumatoid arthritis differentiated from 812 828
saturnine, in lead poisoning 812 926
in transplant patient 814
gp120/160, HIV vaccine development and 1331
GPI (glycosylphosphatidylinositol) anchor deficiency, in paroxysmal nocturnal hemoglobinuria 491
GPT See Alanine aminotransferase
GRACE Risk Score 354
Gradenigo's syndrome 186
Graft-versus-host disease, in HPC transplantation 803
immunosuppressive therapy and 804
Graft-versus-leukemia effect 506
Graft-versus-tumor effect 1661
Graham–Steel murmur 338
Gram-negative infections 1420–1436 1552–1553
bacteremia and sepsis 1423–1424
endocarditis and 1415
folliculitis, acne and 116 118
Gram-positive infections 1400–1414 1552 1553
Gram stain
ascitic fluid 560
in pneumonia diagnosis 251
Grand mal (tonic-clonic) seizures 981–982 981 984
Grand mal (tonic-clonic) status epilepticus 986
Granisetron 540 540 1682
Granular urinary casts 896 897 935
Granulocyte colony-stimulating factor (G-CSF) See Filgrastim
Granulocyte macrophage colony-stimulating factor (GM-CSF) See Sargramostim
Granulocyte transfusion 535
Granulocytic ehrlichiosis/anaplasmosis 1392 1397
Granulocytopenia See also Neutropenia
infections and 1288–1289
Granuloma See also Granulomatosis; Granulomatous disorders
hepatic, drugs/toxins causing 666
inguinale 1433
intubation 210
lethal midline 201
pulmonary, in sarcoidosis 279
swimming pool 1438
P.1802
Granulomatosis
allergic angiitis and See Allergic angiitis and granulomatosis
infantisepticum 1414
Wegener's See Wegener's granulomatosis
Granulomatous disorders See also specific type and Granuloma; Granulomatosis
acanthamoeba causing 1473
gastritis in 585
hypercalcemia in 1152
neck involved in 215–216
of nose and paranasal sinuses 200–202
Granulomatous thyroiditis See Subacute (de Quervain's) thyroiditis
Granulosa cell tumor 745
Graves' dermopathy (pretibial myxedema) 1135 1137 1142
Graves' disease 1135 1138–1140
HLA in 801 1135
thyroid antibodies/TSH receptor antibody in 1118–1119 1135
Graves' ophthalmopathy/exophthalmos (dysthyroid eye disease) 170 1135 1137 1140 1141
Gray top tubes 1743
Great toe, in gout 811
Green poultice, chronic pain disorders and 1050
Green top tubes 1743
Grief reaction/grieving 85 1065–1066
Grippe, summer 1389
Griseofulvin 101
Ground itch, in hookworm disease 1525
Group A beta-hemolytic streptococcal infection 1401–1402 1552
cellulitis 125 1556
endocarditis 1402 1418
erysipelas 124 1401 1556
glomerulonephritis and 915 1400
impetigo 113 1401 1556
pharyngitis 204–206 1400–1401 1556
rapid antigen tests for 205 1400 1401
rheumatic fever and 405 1400 1401
scarlet fever 1400 1402
skin infections 1401
Group B streptococcal infection 1402 1552
endocarditis 1418
in pregnancy 766 780 1402
Group C streptococcal infection 1552
endocarditis 1418
Group D streptococcal infection 1402
endocarditis 1402 1415
Group G streptococcal infection 1552
endocarditis 1418
Group therapy See also Support groups
for anxiety disorders 1047
for chronic pain disorders 1052
for personality disorders 1055
for somatoform disorders 1049
Growth factors See also Filgrastim; Sargramostim
in cancer chemotherapy 1669
for chemotherapy-induced toxicity 1671 1680
for HIV infection/AIDS 1346
for infection in cancer/immunocompromised host 1291 1694
for neutropenia 499
platelet-derived, in myelofibrosis 503
receptors for, blockade of in cancer treatment 1698 1698
Growth hormone (GH)
deficiency of 1105 1106 1107
obesity and 1099
excess of, acromegaly and gigantism caused by 1110–1112
in phosphate metabolism 800
replacement therapy with 1107
for AIDS wasting 1322
for Turner's syndrome 1189
serum levels of
in acromegaly/gigantism 1111
laboratory reference range for 1739
tumors secreting 1106 1191
Guaiac testing See Fecal occult blood testing
Guanabenz 437 438
overdose/toxicity of 1622–1623
Guanadrel 437
Guanethidine 437
antidepressant drug interactions and 1074
monoamine oxidase inhibitor interactions and 1074
Guanfacine 437 438
overdose/toxicity of 1622–1623
Guillain-Barr syndrome (acute idiopathic polyneuropathy) 1026–1027 1367
dysautonomia in 987 1027
influenza vaccination and 1310 1383
Guinea worm infection (dracunculiasis) 1520–1521
Gum disease See Gingivitis
Gummas, in syphilis 1443 1444 1448 1450
Guns See Firearms
Gut See Gastrointestinal system
Gut dialysis, (repeat-dose charcoal) 1613
Guttate psoriasis 97
GW572016 See Lapatanib
Gynecologic disorders 728–762
diagnostic procedures used in 729
in HIV infection/AIDS 1329
Gynecomastia 1100–1101 1101
in hypogonadism 1180 1181
in Klinefelter's syndrome 1180 1707
testicular tumors causing 972 1182 1183
Gypsy moths, skin lesions caused by 136
Gyromitra (monomethylhydrazine) mushroom poisoning 1629 1630 1630
EAN: 2147483647
Pages: 71